Evidence map›Paper›PMID 37465645›Full record

ArticleMaterials advances2023

Modification of bacterial microcompartments with target biomolecules

David M Beal, Mingzhi Liang, Ian Brown, James D Budge, Emily R Burrows, Kevin Howland, Phoebe Lee, Sarah Martin, Andrew Morrell, Emi Nemoto-Smith and 4 more

Abstract read
In one paragraph

Article in Materials advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

David M BealSchool of Biosciences, Division of Natural Sciences, University of Kent Canterbury UK d.m.beal@kent.ac.uk c.m.smales@kent.ac.uk.ORCID https://orcid.org/0000-0002-1819-315X
Mingzhi LiangSchool of Biosciences, Division of Natural Sciences, University of Kent Canterbury UK d.m.beal@kent.ac.uk c.m.smales@kent.ac.uk.
Ian BrownSchool of Biosciences, Division of Natural Sciences, University of Kent Canterbury UK d.m.beal@kent.ac.uk c.m.smales@kent.ac.uk.
James D BudgeSchool of Biosciences, Division of Natural Sciences, University of Kent Canterbury UK d.m.beal@kent.ac.uk c.m.smales@kent.ac.uk.
Emily R BurrowsGSK Stevenage UK.
Kevin HowlandSchool of Biosciences, Division of Natural Sciences, University of Kent Canterbury UK d.m.beal@kent.ac.uk c.m.smales@kent.ac.uk.
Phoebe LeeSchool of Biosciences, Division of Natural Sciences, University of Kent Canterbury UK d.m.beal@kent.ac.uk c.m.smales@kent.ac.uk.
Sarah MartinCatapult: Cell and Gene Therapy London UK.
Andrew MorrellSchool of Biosciences, Division of Natural Sciences, University of Kent Canterbury UK d.m.beal@kent.ac.uk c.m.smales@kent.ac.uk.
Emi Nemoto-SmithCharles River Cambridge UK.
Joanne RoobolSchool of Biosciences, Division of Natural Sciences, University of Kent Canterbury UK d.m.beal@kent.ac.uk c.m.smales@kent.ac.uk.
Maria StanleySchool of Biosciences, Division of Natural Sciences, University of Kent Canterbury UK d.m.beal@kent.ac.uk c.m.smales@kent.ac.uk.
C Mark SmalesSchool of Biosciences, Division of Natural Sciences, University of Kent Canterbury UK d.m.beal@kent.ac.uk c.m.smales@kent.ac.uk.
Martin J WarrenSchool of Biosciences, Division of Natural Sciences, University of Kent Canterbury UK d.m.beal@kent.ac.uk c.m.smales@kent.ac.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacterial microcompartments (BMCs) are proteinaceous organelle-like structures formed within bacteria, often encapsulating enzymes and cellular processes, in particular, allowing toxic intermediates to be shielded from the general cellular environment. Outside of their biological role they are of interest, through surface modification, as potential drug carriers and polyvalent antigen display scaffolds. Here we use a post-translational modification approach, using copper free click chemistry, to attach a SpyTag to a target protein molecule for attachment to a specific SpyCatcher modified BMC shell protein. We demonstrate that a post-translationally SpyTagged material can react with a SpyCatcher modified BMC and show its presence on the surface of BMCs, enabling future investigation of these structures as polyvalent antigen display scaffolds for vaccine development. This post-translational 'click' methodology overcomes the necessity to genetically encode the SpyTag, avoids any potential reduction in expression yield and expands the scope of SpyTag/SpyCatcher vaccine scaffolds to form peptide epitope vaccines and small molecule delivery agents.

Identifiers

PMID37465645
PMCPMC10350929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.